There may have been a significant increase in the amount of regulatory activity at EU level of late, but the medtech industry remains alarmed at the lack of readiness of the system, and calls for an urgent focus on IVDs now too.
Devoting the same level of attention and energy to the IVD Regulation as to the Medical Device Regulation is long overdue. That is the view of the EU’s largest medtech industry association, MedTech Europe, in a statement put out to mark the half-way point of the EU IVD Regulation’s five-year transition period and the six-month countdown to the MDR.
MedTech Europe notes that the IVDR will bring an estimated eight-fold workload increase to IVD notified bodies.
“It is clear that the EU needs to start urgently and proactively addressing this situation if patients and healthcare systems are to retain access to diagnostic tests,” it says.
The association says it is “alarmed” that only about ten organizations have applied so far to be notified bodies under the IVDR, with just two and a half years until the date of full application of the IVDR, on 26 May 2022.
Of the ten, only BSI UK and DEKRA have been designated so far, Medtech Insight notes.
Delays, Errors And Confusion
Despite the designation of seven notified bodies under the MDR and the two under the IVDR), the recent barrage of guidance documents, MedTech Europe is in no doubt that the tools needed for implementation are coming too slowly and too late.
Medtech Insight, meanwhile, also notes that the recent rapid proliferation of decisions and documents intended to support MDR and IVDR implementation is starting to result in multiple situations littered with ambiguity, and even errors, which will make compliance difficult, if not impossible. One instance of this is the EU software guidance document; another is the huge challenges being brought about by factoring in and indeed understanding the delay in the introduction of Eudamed 3, the updated version of the EU’s medical device database.
“We remain seriously held back by the slow and piecemeal implementation of the new regulatory framework,” the MedTech Europe says.
The incomplete implementation by EU member states and European Commission of the MDR and the IVDR threatens the continuity of patient access and care, both in Europe and beyond, the association says. It argues that this will impact not just the EU, but “more than 100 countries around the world that rely on the EU CE marking of medical technologies.”
Medtech Insight: 世界の医療機器・医療技術の最新情報
By Ashley Yeo 10 Aug 2020
Hospital administrators and clinicians in Germany seek enhanced digitization of clinical procedures, but the budgets have not always been available...
Medtech Insight: 世界の医療機器・医療技術の最新情報
08 Aug 2020
AdvaMed Accell executive director Ashley Wittorf spoke in support of a proposed US House bill that would give financial help...
Medtech Insight: 世界の医療機器・医療技術の最新情報
By $name 07 Aug 2020
The current pandemic has accelerated the US FDA’s perspective on conducting remote clinical trials. The agency has published an emergency...
製品説明＆デモお申込
専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。
＊一部のサービスでは無料トライアルをご利用になれません。
お問い合わせ先
ご質問等ございましたらお気軽にご連絡下さい。
日本（平日：9時～18時）
電話：+81 (0)3 6273 4260
Email：inquiry.jp@informa.com
レポートストア
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。
Meddevicetracker(メッドデバイストラッカー)は、医療機器の開発状況について適応疾患や医療機器のタイプから検索できるツールです。1,000社以上の会社による5,000を超える製品群、2,000件以上の医療機器の臨床試験など比類ない規模で医療機器市場を網羅しています。
In Vivo(インビボ)は、医療用医薬品の企業全般、バイオ医薬品企業、医療機器・診断機器メーカーの経営層・トップマネジメントを対象としたニュース配信サービスです。35年以上の経験を有するベテランの専門記者とアナリストが様々な観点から今日の医薬品産業を分析し、経営層のハイレベルかつグローバルな情報ニーズに応えるニュースや読み応えのある記事を提供しています。
